Durlobactam API Suppliers - Manufacturers and Distributors

Lixinpharm is a GMP manufacturer of APIs and intermediates in China. We're FDA approved and we targeted at regulated markets. We focus on Oncology, cardiovaslucar, nootropics.

Maharshi Pharmachem is the fastest growing company in India, having plans to expand our market reach further. We have the conviction that all markets should be provided with quality products. We are constantly working on Regulated and semi-regulated markets by tying up with sever l partners with common vision and goals. With our present infrastructure, qualitative & quality products, and well-established brand image, as a reli...Maharshi Pharmachem is the fastest growing company in India, having plans to expand our market reach further. We have the conviction that all markets should be provided with quality products. We are constantly working on Regulated and semi-regulated markets by tying up with several partners with common vision and goals. With our present infrastructure, qualitative & quality products, and well-established brand image, as a reliable group of people with the best potential to deliver quality healthcare solutions to the world. - Show More

Founded in 2003, Zhejiang Tianyu Pharmaceutical Co., Ltd. is a joint-stock pharmaceutical company specializing in the research, development and manufacture of APIs and advanced pharmaceutical intermediates. The company has a registered capital of 120 million yuan and covers an ar a of ​​700 mu. The factory has more than 2,600 employees. - Show More

AVA is a Swiss-American manufacturer of connected home products. With a focus on audio streaming and home control, AVA creates products that delight, improve quality of life, feel natural to use, and fit seamlessly into any living space. AVA is led by a highly talented and experi nced team who come from the pro world and have spent the last several years hard at work designing their dream products for the professional channel...AVA is a Swiss-American manufacturer of connected home products. With a focus on audio streaming and home control, AVA creates products that delight, improve quality of life, feel natural to use, and fit seamlessly into any living space. AVA is led by a highly talented and experienced team who come from the pro world and have spent the last several years hard at work designing their dream products for the professional channel, which is why AVA’s products are sold exclusively through authorized professional installers. - Show More

Benzo Chem Industries Private Limited and Gitanjali Chemicals Private Limited are wholly owned companies of Mohatta Group. It all began three decades ago in 1982; Gitanjali Chemicals Pvt. Limited was first incepted with the production of phthalate plasticizers. Soon the company h s developed substantial competencies in the areas of biocides, pharmaceuticals and performance chemicals. Today the company’s range of products in...Benzo Chem Industries Private Limited and Gitanjali Chemicals Private Limited are wholly owned companies of Mohatta Group. It all began three decades ago in 1982; Gitanjali Chemicals Pvt. Limited was first incepted with the production of phthalate plasticizers. Soon the company has developed substantial competencies in the areas of biocides, pharmaceuticals and performance chemicals. Today the company’s range of products include Chlorophenol derivatives, Diclofenac Sodium and Miconazole Nitrate intermediates, Benzophenones, Acetophenones, Anisole and Phenetole derivatives. Since then the company never looked back. Innovative products with the environmentally greener processes and fast system solutions enabled us to expand further to incorporate Benzo Chem Industries Pvt. Limited in 1986 at Jalgaon and 1997 at Malkapur in Maharashtra, about 400 kms from Mumbai. In 2009 a new 100% Export Oriented Unit has been in operation at Malkpur. We also have GMP plant certified by SGS Europe which is located at Ambernath, near Mumbai. The products list widened with these new establishments and company became market leader in the manufacturing products based on chlorination and cyanation. With the passage of time the company diversified its production expertise and started producing derivatives based on Para Chloro Toluene, 2,4-Dichloro Toluene, Meta Chloro Toluene, Ortho Chloro Toluene, 3,4-Dichloro Toluene and specialty products. With such a track record and quality culture all 4 factories earned ISO 9001-2008, ISO 14001-2004 and OHSAS 18001-2007 recognition from IQCS, India. State-of-the-art process research facilities, Ultra-modern Quality Control Laboratory equipped with sophisticated analytical instruments, Strong R&D team made us to convert market trends and scientific ideas quickly into successful new products and process innovations. We offer world class service from Kilo to ton lots from our product range. The company has established a global presence through the export of its range of products to USA, Brazil, Europe, Japan, Korea, Taiwan etc. Long term success and responsibilities for the society go hand in hand for us. We take pride in maintaining healthy relationship with the environment by installation of modern effluent treatment plant. - Show More

Curia is a global contract research, development and manufacturing organization (CDMO), offering products and services across the drug development spectrum to help our partners turn their ideas into real-world impact. We partner closely with pharmaceutical and biotechnology compa ies to boost business performance and improve patients’ lives. From early discovery and development through manufacturing and commercialization, ou...Curia is a global contract research, development and manufacturing organization (CDMO), offering products and services across the drug development spectrum to help our partners turn their ideas into real-world impact. We partner closely with pharmaceutical and biotechnology companies to boost business performance and improve patients’ lives. From early discovery and development through manufacturing and commercialization, our suite of custom solutions allows us to tailor every engagement to your precise needs, whether that’s an independent project or an opportunity that cuts across the drug continuum. - Show More

Dow Pharma & Medical is a global leader in research, manufacturing and innovation of functional excipients, API’s and silicon-based technologies for medical device fabrication and pharmaceutical processing. It has the material science expertise and global market and regulatory xperience to help customers deliver innovative solutions for healthcare challenges of today and tomorrow; bringing new products to market faster and ...Dow Pharma & Medical is a global leader in research, manufacturing and innovation of functional excipients, API’s and silicon-based technologies for medical device fabrication and pharmaceutical processing. It has the material science expertise and global market and regulatory experience to help customers deliver innovative solutions for healthcare challenges of today and tomorrow; bringing new products to market faster and extending product life-cycles. - Show More

Helios Life Sciences is an organization of dedicated, innovative and enterprising leaders who envision a world where everyone has access to high-quality affordable medication. We are emerging leaders in manufacturing and supplying high-value, low-volume APIs. We also manufacture ntermediate molecules. Our specialization is in Oncology and biological molecules. - Show More

Sinco Pharma is the fourth largest marketing, promotion and channel management service provider in the PRC pharmaceutical industry with a market share of 4.2% in terms of revenue for 2016. We are also the only marketing, promotion and channel management service provider for plasm -based pharmaceuticals. The plasma-based pharmaceuticals market in China grew at a CAGR of 25.4% from 2012 to 2016. It is expected to reach RMB98.14 ...Sinco Pharma is the fourth largest marketing, promotion and channel management service provider in the PRC pharmaceutical industry with a market share of 4.2% in terms of revenue for 2016. We are also the only marketing, promotion and channel management service provider for plasma-based pharmaceuticals. The plasma-based pharmaceuticals market in China grew at a CAGR of 25.4% from 2012 to 2016. It is expected to reach RMB98.14 billion in 2021, representing a CAGR of 26.1% from 2017. China’s human albumin market grew rapidly at a CAGR of 22.2%, and is expected to grow at a CAGR of 22.8% from 2017 to 2021. - Show More